ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists (Xconomy.com)

ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists

(UF startup Banyan Biomarkers is a finalist in the Xconomy Awards San Diego. Banyan Biomarkers’ FDA-approved brain trauma indicator is a result of UF researcher. The company incubated at UF Innovate | Sid Martin Biotech and maintains a presence in both Alachua and in San Diego.)

The finalists in the Big Idea category of the Xconomy Awards San Diego are pursuing ambitious goals in pursuit of better ways of improving health. Their approaches range, from a new way to deliver insulin to patients with Type 1 diabetes to an innovative method to detect brain trauma that could reduce the need for medical imaging. Here are brief profiles of the finalists.

Banyan Biomarkers

Banyan Biomarkers has developed a new way to determine whether a patient has suffered brain trauma. The test measures levels of certain proteins in the blood to evaluate whether the brain is functioning normally following an injury…

Learn more about ViaCyte, Fate & More: Xconomy Awards San Diego Big Idea Finalists.
X